Literature DB >> 8459222

A rat CD4 mutant containing the gp120-binding site mediates human immunodeficiency virus type 1 infection.

J H Simon1, C Somoza, G A Schockmel, M Collin, S J Davis, A F Williams, W James.   

Abstract

CD4 is the primary receptor for the human immunodeficiency virus type 1 (HIV-1). Early mutational studies implicated a number of residues of CD4, centered in the region 41-59, in binding to gp120. However, further mutational analyses, together with studies using inhibitory antibodies or CD4-derived peptides, have suggested that other regions of CD4 are also involved in binding or postbinding events during infection. To resolve these ambiguities, we used rat CD4 mutants in which particular regions were replaced with the corresponding sequence of human CD4. We have previously shown that some of these are able to bind HIV-1 gp120, and here we test their ability to act as functional receptors. We find that the presence of human CD4 residues 33-62 is enough to confer efficient receptor function to rat CD4, and we conclude that it is unlikely that regions of CD4 outside this sequence are involved in specific interactions with HIV-1 during either infection or syncytium formation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8459222      PMCID: PMC2190986          DOI: 10.1084/jem.177.4.949

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  37 in total

1.  Effects of CD4 synthetic peptides on HIV type I envelope glycoprotein function.

Authors:  H Repke; D Gabuzda; G Palù; F Emmrich; J Sodroski
Journal:  J Immunol       Date:  1992-09-01       Impact factor: 5.422

2.  COCAL VIRUS, A NEW AGENT IN TRINIDAD RELATED TO VESICULAR STOMATITIS VIRUS, TYPE INDIANA.

Authors:  A H JONKERS; R E SHOPE; T H AITKEN; L SPENCE
Journal:  Am J Vet Res       Date:  1964-01       Impact factor: 1.156

3.  HIV interactions with CD4: a continuum of conformations and consequences.

Authors:  L E Eiden; J D Lifson
Journal:  Immunol Today       Date:  1992-06

4.  Construction of a binding site for human immunodeficiency virus type 1 gp120 in rat CD4.

Authors:  G A Schockmel; C Somoza; S J Davis; A F Williams; D Healey
Journal:  J Exp Med       Date:  1992-01-01       Impact factor: 14.307

5.  Polyoma transformation of hamster cell clones--an investigation of genetic factors affecting cell competence.

Authors:  I MACPHERSON; M STOKER
Journal:  Virology       Date:  1962-02       Impact factor: 3.616

6.  Complete nucleotide sequence of the AIDS virus, HTLV-III.

Authors:  L Ratner; W Haseltine; R Patarca; K J Livak; B Starcich; S F Josephs; E R Doran; J A Rafalski; E A Whitehorn; K Baumeister
Journal:  Nature       Date:  1985 Jan 24-30       Impact factor: 49.962

7.  A simple micro-culture method for the study of group B arboviruses.

Authors:  A T De Madrid; J S Porterfield
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

8.  Restricted expression of human T-cell leukemia--lymphoma virus (HTLV) in transformed human umbilical cord blood lymphocytes.

Authors:  S Z Salahuddin; P D Markham; F Wong-Staal; G Franchini; V S Kalyanaraman; R C Gallo
Journal:  Virology       Date:  1983-08       Impact factor: 3.616

9.  CD4 molecules with a diversity of mutations encompassing the CDR3 region efficiently support human immunodeficiency virus type 1 envelope glycoprotein-mediated cell fusion.

Authors:  C C Broder; E A Berger
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

10.  Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS.

Authors:  M Popovic; M G Sarngadharan; E Read; R C Gallo
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

View more
  14 in total

1.  Residue Trp-48 of Tva is critical for viral entry but not for high-affinity binding to the SU glycoprotein of subgroup A avian leukosis and sarcoma viruses.

Authors:  K Zingler; J A Young
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

2.  Structural characterization of an anti-gp120 RNA aptamer that neutralizes R5 strains of HIV-1.

Authors:  Antu K Dey; Carla Griffiths; Susan M Lea; William James
Journal:  RNA       Date:  2005-06       Impact factor: 4.942

3.  Inhibition of HIV-1 replication by ribozymes that show poor activity in vitro.

Authors:  P Crisell; S Thompson; W James
Journal:  Nucleic Acids Res       Date:  1993-11-11       Impact factor: 16.971

4.  Adaptation of human immunodeficiency virus type 1 to cells expressing a binding-deficient CD4 mutant (lysine 46 to aspartic acid).

Authors:  H R Choe; J Sodroski
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

5.  Peptide ligands to human immunodeficiency virus type 1 gp120 identified from phage display libraries.

Authors:  M Ferrer; S C Harrison
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

6.  Functional epitope analysis of the human CD4 molecule: antibodies that inhibit human immunodeficiency virus type 1 gene expression bind to the immunoglobulin CDR3-like region of CD4.

Authors:  M Benkirane; M Hirn; D Carrière; C Devaux
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

7.  The alpha-glucosidase inhibitor N-butyldeoxynojirimycin inhibits human immunodeficiency virus entry at the level of post-CD4 binding.

Authors:  P B Fischer; M Collin; G B Karlsson; W James; T D Butters; S J Davis; S Gordon; R A Dwek; F M Platt
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

Review 8.  HIV-1 proteins in infected cells determine the presentation of viral peptides by HLA class I and class II molecules and the nature of the cellular and humoral antiviral immune responses--a review.

Authors:  Y Becker
Journal:  Virus Genes       Date:  1994-07       Impact factor: 2.332

9.  Cell fusion mediated by interaction of a hybrid CD4.CD8 molecule with the human immunodeficiency virus type 1 envelope glycoprotein does occur after a long lag time.

Authors:  H Golding; R Blumenthal; J Manischewitz; D R Littman; D S Dimitrov
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

10.  Determinants of human immunodeficiency virus type 1 entry in the CDR2 loop of the CD4 glycoprotein.

Authors:  D Brand; K Srinivasan; J Sodroski
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.